Literature DB >> 8174730

Tamoxifen treatment in male infertility. I. Effect on spermatozoa.

I G Kotoulas1, E Cardamakis, J Michopoulos, D Mitropoulos, A Dounis.   

Abstract

OBJECTIVE: To evaluate the effects of tamoxifen treatment on sperm density, motility, vitality, and morphology.
DESIGN: Placebo-controlled, randomized study.
SETTING: Outpatient department.
INTERVENTIONS: Patients were assigned to two comparable groups: group A (n = 122) was treated with 10 mg tamoxifen twice daily for a period of 3 months and group B (n = 117) was given placebo for the same period of time, following a previously randomized design. MAIN OUTCOME MEASURES: In every patient sperm density, motility, viability, and morphology were evaluated 3 months after cessation of treatment.
RESULTS: Mean sperm density in group A improved significantly with a more pronounced improvement in severe oligozoospermic men. Sperm density was found significantly improved compared with group B. Dead spermatozoa in group A significantly decreased after tamoxifen treatment and were also found significantly decreased compared with group B.
CONCLUSION: It is concluded that tamoxifen exerts a beneficial effect on sperm density and number of live spermatozoa but it has no substantial effect in sperm motility and morphology.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8174730     DOI: 10.1016/s0015-0282(16)56705-3

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  12 in total

1.  The Role of Estrogen Modulators in Male Hypogonadism and Infertility.

Authors:  Amarnath Rambhatla; Jesse N Mills; Jacob Rajfer
Journal:  Rev Urol       Date:  2016

Review 2.  The Estrogen Receptor α-Cistrome Beyond Breast Cancer.

Authors:  Marjolein Droog; Mark Mensink; Wilbert Zwart
Journal:  Mol Endocrinol       Date:  2016-08-04

3.  Genetic polymorphisms of CYP2D6*10 and the effectiveness of combined tamoxifen citrate and testosterone undecanoate treatment in infertile men with idiopathic oligozoospermia.

Authors:  Kai-fa Tang; Yi-li Zhao; Shang-shu Ding; Qi-fei Wu; Xing-yang Wang; Jia-qi Shi; Fa Sun; Jun-ping Xing
Journal:  J Zhejiang Univ Sci B       Date:  2015-03       Impact factor: 3.066

Review 4.  Advances in the evaluation and treatment of the infertile man.

Authors:  E D Kim; L I Lipshultz
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

Review 5.  Oestrogens and spermatogenesis.

Authors:  Serge Carreau; Rex A Hess
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2010-05-27       Impact factor: 6.237

6.  Oral tamoxifen citrate treatment is more effective in normogonadotropic patients who have follicle-stimulating hormone levels within the lower half of normal.

Authors:  Teoman Cem Kadioglu
Journal:  Int Urol Nephrol       Date:  2009-04-21       Impact factor: 2.370

7.  Tamoxifen is a potent antioxidant modulator for sperm quality in patients with idiopathic oligoasthenospermia.

Authors:  Li Guo; Jun Jing; Yu-Ming Feng; Bing Yao
Journal:  Int Urol Nephrol       Date:  2015-07-28       Impact factor: 2.370

Review 8.  The hormonal control of ejaculation.

Authors:  Giovanni Corona; Emmanuele A Jannini; Linda Vignozzi; Giulia Rastrelli; Mario Maggi
Journal:  Nat Rev Urol       Date:  2012-08-07       Impact factor: 14.432

9.  More attention should be paid to the treatment of male infertility with drugs--testosterone: to use it or not?

Authors:  Hong-Jun Li
Journal:  Asian J Androl       Date:  2014 Mar-Apr       Impact factor: 3.285

Review 10.  Estrogens as antioxidant modulators in human fertility.

Authors:  A Mancini; S Raimondo; M Persano; C Di Segni; M Cammarano; G Gadotti; A Silvestrini; A Pontecorvi; E Meucci
Journal:  Int J Endocrinol       Date:  2013-11-20       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.